IN-VITRO DIAGNOSTICS MARKET 2018 INDUSTRY ANALYSIS, GROWTH, SIZE, SHARE, TRENDS, FORECAST TO 2022

Pune, India, 16th April 2018: WiseGuyReports announced addition of new report, titled “Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2017-2021)”.

Pune, India - April 16, 2018 /MarketersMedia/ —

Diagnosis is the identification of the nature and cause of a certain phenomenon. It involves two different types of testing method: in vivo and in vitro diagnostics. In-vitro diagnostics (IVDs) tests are defined as tests executed outside a patient’s body which put analytical instruments, devices, reagents, calibrators and systems to use for checking of health status or diagnosing diseases. Purpose for doing the IVD test is to prevent, effectively cure and mitigate any kind of risk and for post-treatment intensive care diseases and infections. IVD products are precisely designed and produced for collecting samples derived from the human body and scrutinizing them outside the human body.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2379202-global-in-vitro-diagnostics-ivd-market-industry-analysis-outlook-2017-2021

The global IVD market is segmented on the basis of product, technology used and test location. On the basis of product, this market can be divided into three sub segments; reagents, analytical instruments and accessory products. By technologies employed, it can be segmented into various sub segments; immunochemistry, SMBG, POCT, molecular diagnostics, clinical chemistry, microbiology, hematology and others. Further, depending upon test location, the market can be divided into three sub segments; labs, POC and self-test.

Growth of the global IVD market is driven by several factors including rapid occurrence of infectious diseases, increasing diabetic patient base, and surge in incidences of chronic ailments. Further, growing geriatric population, rising GDP per capita and increasing healthcare expenditure per capita will act as a catalyst for market growth. Owing to the suitable demographical changes and rising disposable income coupled with improving basic infrastructure, developing regions such as Asia-Pacific and Latin America are expected to experience robust growth. However, the market growth prospects could be hindered by lack of customer adoption, lack of proper facilities and infrastructure and strict government regulations.

The report “Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2017-2021)” analyzes the development of this market, with focus on the North America, EMEA, Asia-Pacific and Latin America markets. The major trends, growth drivers as well as issues faced by the market are discussed in detail in this report. The four major players: Siemens AG., Roche Holdings AG., Abbott Laboratories and Danaher Corp. are being profiled along with their key financials and strategies for growth.

Table of Content: Key Points

1. Overview
1.1 In-Vitro Diagnostics (IVD)
1.2 IVD Product by Types
1.3 IVD Tests
1.4 IVD Market by Technology
1.5 IVD Uses
1.6 IVD Value Chain Analysis

2. Global IVD Market
2.1 Global IVD Market by Value
2.2 Global IVD Market Forecast by Value
2.3 Global IVD Market by Region
2.4 Global IVD Market by Indications
2.5 Global IVD Market by Test Location
2.6 Global IVD Market by Product
2.6.1 Global IVD Reagents Market Forecast by Value
2.6.2 Global IVD Instrument Market Forecast by Value
2.7 Global IVD Market by Technology

3. Global IVD Market Analysis by Technology
3.1 Global SMBG Market Forecast by Value
3.2 Global Clinical Chemistry Market Forecast by Value
3.3 Global Immunochemistry Market
3.3.1 Global Immunochemistry Market Forecast by Value
3.3.2 Global Immunochemistry Market by Indications
3.4 Global Molecular Diagnostics Market
3.4.1 Global Molecular Diagnostics Market Forecast by Value
3.4.2 Global Molecular Diagnostics Market by Indications
3.4.3 Global Molecular Diagnostics Market by Regions
3.5 Global Point Of Care (POC) Market Forecast by Value
3.6 Global Microbiology Market
3.6.1 Global Microbiology Market Forecast by Value
3.6.2 Global Microbiology Market by Indication
3.7 Global Hematology Market Forecast by Value

4. Regional IVD Market
4.1 North America
4.1.1 North America IVD Market Forecast by Value
4.1.2 North America Microbiology Market by Indication
4.1.3 The US IVD Market Forecast by Value
4.2 EMEA
4.2.1 EMEA IVD Market Forecast by Value
4.2.2 Europe Microbiology Market by Indications
4.3 Asia-Pacific
4.3.1 Asia-Pacific IVD Market Forecast by Value
4.3.2 China IVD Market Forecast by Value
4.3.3 Japan IVD Market Forecast by Value
4.4 Latin America
4.4.1 Latin America IVD Market Forecast by Value

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Diabetic Patient Base
5.1.2 Rapid Occurrence of Infectious Diseases
5.1.3 Surge in Incidences of Chronic Ailments
5.1.4 Increasing Global Healthcare Expenditure Per Capita
5.1.5 Rising Global GDP per Capita
5.1.6 Growing Geriatric Population

5.2 Key Trends & Developments
5.2.1 Rise in CFDA IVD Market Approvals
5.2.2 Consolidation of Core Labs
5.2.3 Increasing Penetration of the US LDT Companies in European IVD Market
5.2.4 Mergers & Acquisitions

5.3 Challenges
5.3.1 Lack of Customer Adoption
5.3.2 Urgent Need for Proper Infrastructure
5.3.3 Government Regulation for IVD Tests

6. Competitive Landscape
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2379202-global-in-vitro-diagnostics-ivd-market-industry-analysis-outlook-2017-2021

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: Norah Trent
Email: sales@wiseguyreports.com
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Pune - 411028
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/in-vitro-diagnostics-market-2018-industry-analysis-growth-size-share-trends-forecast-to-2022/331595

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 331595

Latest News

Cybersecurity 'Paul Revere' touts adversarial model

Oct 21, 2018

BURLINGTON, Mass. — Chris Wysopal and his Boston hacker collective pals from the L0pht sounded the alarm on the sad state of software vulnerability in a now-legendary 1998 appearance before Congress. Then-Sen. Joe Lieberman hailed the group as "modern-day Paul Reveres." Wysopal remains active in cybersecurity today as chief technology officer of Veracode, now part of CA Technologies. He spoke with The Associated Press recently on the state of security. Questions and responses have been edited for clarity and length. Q: How did Microsoft in 2002 come to embrace the mindset of allowing friendly, "white-hat" hackers to pick apart software...

Snake names honor Darwin, fire god, Louisiana professor

Oct 21, 2018

NEW ORLEANS — A Louisiana professor is in heady company, honored by having one of three newly identified species of snakes from the Galapagos Islands named after him. "They named one after Charles Darwin — that's a no-brainer — and one after the Greek god of fire, and one after me, of all people," said Robert A. Thomas , an environmental biologist and head of head of the Center for Environmental Communication at Loyola University New Orleans. The snake in question, a handsome critter with lengthwise brown and creamy yellow stripes, is called Pseudalsophis thomasi (sood-al-SO-fis TOM-uhs-eye). "I've got a...

What's next for Paul Allen's big investments? It's not clear

Oct 21, 2018

SEATTLE — Prior to his death on Monday, billionaire Microsoft co-founder Paul Allen invested large sums in technology ventures, research projects and philanthropy, some of it eclectic and highly speculative. What happens to those commitments now? Outside of bland assurances from his investment company, no one seems quite sure. Allen died in Seattle from complications of non-Hodgkin's lymphoma, according to his company Vulcan Inc. He was 65. He never married and had no children, and details of his estate aren't known. Forbes recently estimated Allen's net worth at $20.3 billion. He used much of the money he made from Microsoft...

Treasury employee charged in leak linked to Mueller's probe

Oct 21, 2018

WASHINGTON — A Treasury Department employee was accused Wednesday of leaking confidential banking reports of suspects charged in special counsel Robert Mueller's investigation, and an unidentified high-ranking colleague was cited in court papers as a co-conspirator but was not charged. Natalie Mayflower Sours Edwards, a senior official at the department's Financial Crimes Enforcement Network, also known as FinCEN, is accused of leaking several confidential suspicious activity reports to a journalist, whose name was not disclosed in court papers. But the documents list about a dozen stories published by BuzzFeed News over the past year and a half. A spokesman for...

Paul Allen's passions: Rock n' roll, sports and philanthropy

Oct 21, 2018

SEATTLE — Personal computers, conservation, pro football, rock n' roll and rocket ships: Paul G. Allen couldn't have asked for a better way to spend, invest and donate the billions he reaped from co-founding Microsoft with childhood friend Bill Gates. Allen used the fortune he made from Microsoft — whose Windows operating system is found on most of the world's desktop computers — to invest in other ambitions, from tackling climate change and advancing brain research to finding innovative solutions to solve some of the world's biggest challenges. "If it has the potential to do good, then we should do...

Sign up now!